This is the kind of study we need (ie. long-term)
"Responses of African Savanna Trees to Large Herbivore Extinction and Rewilding"
onlinelibrary.wiley.com/doi/10.1111/... #herbivores #ecologicalfunction #vegetation #extinction #rewilding #efficacy
Help! Hoe komen we uit deze negatieve spiraal. Draagvlak voor klimaat- en natuurbeleid is groot. Maar we blijven elkaar maar wijs maken dat dat niet zo is. Komt politici die belang hebben bij business as usual heel goed uit. En burgers zakken verder weg in moedeloosheid. #efficacy #climatepsychology
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TRTBHw #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TRRj7w !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TRQxmX
@ASCO
#SocialListening #LucidQuest
Your power comes from within. ✨
When you build Hope, Efficacy, Resilience, and Optimism, you become unstoppable.
#InnerHERO #PsyCap #Leadership #SelfDevelopment #Hope #Resilience #Efficacy #Optimism #mindsetmatters
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TRHQBl #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TRGBBY !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TRF805
@ASCO
#SocialListening #LucidQuest
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TR6KTD #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TR5FBn !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TR4sCY
@ASCO
#SocialListening #LucidQuest
🚨New Pub🚨
We explored the #conceptualization of #PCC as an external motivation of #telehealth #efficacy.
Also tested how the previously one-dimensional #patient #activation could be operationalized in 4 steps, translating PCC into telehealth-specific efficacy.
www.tandfonline.com/eprint/NZQMT...
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQy60q #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQwYdy !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TQvxV7
@ASCO
#SocialListening #LucidQuest
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQmjqy #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQlR2m !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TQkJJF
@ASCO
#SocialListening #LucidQuest
Protective #efficacy of a genetically modified attenuated #vaccinia virus #Tiantan strain against #monkeypox virus challenge in a small animal #model, etidiohnew.blogspot.com/2026/01/prot...
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQbRtN #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQZ1zb !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TQYRN4
@ASCO
#SocialListening #LucidQuest
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQRMpy #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQQByH !
#Oncology #SocialListening #LucidQuest
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TQPfK2
@ASCO
#SocialListening #LucidQuest
Read the #show notes from the latest #podcast episode with Glenn Forbes & Jenni Donohoo who talk about ow to counteract each of the enemies of #teacher #efficacy
danagoodier.com/episodes-388...
Immune Checkpoint Inhibitors in High-grade Gastroenteropancreatic Neuroendocrine Neoplasms. Read more in #EndocrineReviews: bit.ly/44vELgI #HighGradeNeuroendocrineNeoplasms #ImmuneCheckpointInhibitors #Efficacy @endocrinesociety.bsky.social
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQHLC0 #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TQGMGG !
#Oncology #SocialListening #LucidQuest